Company Filing History:
Years Active: 2022-2024
Title: Leena Philominathan: Innovator in Antibody Formulations
Introduction
Leena Philominathan is a notable inventor based in the United States. She has made significant contributions to the field of biochemistry, particularly in the development of antibody formulations. Her work focuses on creating stable solutions that can be used in therapeutic applications.
Latest Patents
Leena Philominathan holds a patent for "High Concentration Anti-C5 Antibody Formulations." This patent describes stable aqueous solutions that contain a high concentration of an anti-C5 antibody, such as ravulizumab. The patent also outlines methods for preparing these solutions and their applications in treating or preventing complement-associated disorders, including paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
Career Highlights
Throughout her career, Leena has focused on innovative solutions in the medical field. Her research has the potential to improve treatment options for patients suffering from serious health conditions. Although she currently holds no patents, her work is recognized for its importance in advancing therapeutic methods.
Collaborations
Leena has collaborated with several professionals in her field, including Stephan Ortiz and Jillian Gentile. These collaborations have contributed to the development of her patented formulations and have enhanced the impact of her research.
Conclusion
Leena Philominathan is an influential inventor whose work in antibody formulations is paving the way for new therapeutic solutions. Her contributions to the field are significant, and her ongoing research holds promise for future advancements in medical treatments.